{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:01:12Z","timestamp":1761919272291,"version":"build-2065373602"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ccm.2009.08.014","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T09:08:56Z","timestamp":1258535336000},"page":"811-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["New Vaccines Against Tuberculosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Paul-Henri","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Hawkridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem A.","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccm.2009.08.014_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/14760584.7.5.635","article-title":"Tuberculosis: vaccines in the pipeline","volume":"7","author":"Ly","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"10.1016\/j.ccm.2009.08.014_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(08)70182-8","article-title":"Paediatric tuberculosis","volume":"8","author":"Newton","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2009.08.014_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1055\/s-0028-1085700","article-title":"Global epidemiology of tuberculosis: prospects for control","volume":"29","author":"L\u00f6nnroth","year":"2008","journal-title":"Semin Respir Crit Care Med"},{"issue":"9633","key":"10.1016\/j.ccm.2009.08.014_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)61036-3","article-title":"Tuberculosis vaccine development: goals, immunological design, and evaluation","volume":"372","author":"Hoft","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccm.2009.08.014_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","article-title":"Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis","volume":"27","author":"Horwitz","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ccm.2009.08.014_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"10.1016\/j.ccm.2009.08.014_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0197-2456(94)90042-6","article-title":"Field trials of tuberculosis vaccines: how could we have done them better?","volume":"15","author":"Comstock","year":"1994","journal-title":"Control Clin Trials"},{"issue":"3","key":"10.1016\/j.ccm.2009.08.014_bib8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2223\/JPED.1499","article-title":"BCG vaccine: efficacy and indications for vaccination and revaccination","volume":"82","author":"Barreto","year":"2006","journal-title":"J Pediatr (Rio J)"},{"issue":"9517","key":"10.1016\/j.ccm.2009.08.014_bib9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ccm.2009.08.014_bib10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccm.2009.08.014_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ccm.2009.08.014_bib12","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette-Gu\u00e9rin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ccm.2009.08.014_bib13","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.ccm.2009.08.014_bib14","first-page":"153","article-title":"What has Karonga taught us? Tuberculosis studied over three decades","volume":"13","author":"Crampin","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.ccm.2009.08.014_bib15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/clinids\/20.4.982","article-title":"Geographic latitude and the efficacy of bacillus Calmette-Gu\u00e9rin vaccine","volume":"20","author":"Wilson","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2009.08.014_bib16","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"10.1016\/j.ccm.2009.08.014_bib17","first-page":"801","article-title":"Surgical complications of bacille Calmette-Gu\u00e9rin (BCG) infection in HIV-infected children: time for a change in policy","volume":"98","author":"Karpelowsky","year":"2008","journal-title":"S Afr Med J"},{"issue":"4","key":"10.1016\/j.ccm.2009.08.014_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1086\/499953","article-title":"Bacille Calmette-Gu\u00e9rin vaccine-induced disease in HIV-infected and HIV-uninfected children","volume":"42","author":"Hesseling","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"36","key":"10.1016\/j.ccm.2009.08.014_bib19","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.vaccine.2007.06.045","article-title":"BCG and HIV reconsidered: moving the research agenda forward","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.ccm.2009.08.014_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1086\/597304","article-title":"HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Gu\u00e9rin vaccine","volume":"199","author":"Mansoor","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2009.08.014_bib21","first-page":"1376","article-title":"Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants","volume":"12","author":"Hesseling","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2009.08.014_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vaccine.2006.07.020","article-title":"The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children","volume":"25","author":"Hesseling","year":"2007","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ccm.2009.08.014_bib23","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"10.1016\/j.ccm.2009.08.014_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thorax.57.9.804","article-title":"A meta-analysis of the effect of Bacille Calmette Gu\u00e9rin vaccination on tuberculin skin test measurements","volume":"57","author":"Wang","year":"2002","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.ccm.2009.08.014_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1515\/BC.2008.057","article-title":"Not to wake a sleeping giant: new insights into host-pathogen interactions identify new targets for vaccination against latent Mycobacterium tuberculosis infection","volume":"389","author":"Lin","year":"2008","journal-title":"Biol Chem"},{"issue":"3\u20134","key":"10.1016\/j.ccm.2009.08.014_bib26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tube.2006.01.016","article-title":"Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis","volume":"86","author":"Locht","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"10.1016\/j.ccm.2009.08.014_bib27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1084\/jem.20031097","article-title":"Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis","volume":"199","author":"Gilleron","year":"2004","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.ccm.2009.08.014_bib28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chembiol.2008.11.008","article-title":"Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells","volume":"16","author":"Layre","year":"2009","journal-title":"Chem Biol"},{"issue":"5","key":"10.1016\/j.ccm.2009.08.014_bib29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/eji.200737889","article-title":"Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells","volume":"38","author":"Kamath","year":"2008","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.ccm.2009.08.014_bib30","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.vaccine.2005.10.002","article-title":"A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG","volume":"24","author":"Horwitz","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.ccm.2009.08.014_bib31","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/592450","article-title":"A new recombinant bacille Calmette-Gu\u00e9rin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers","volume":"198","author":"Hoft","year":"2008","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.ccm.2009.08.014_bib32","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Gu\u00e9rin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ccm.2009.08.014_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2005.12.001","article-title":"Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis","volume":"24","author":"Winau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.ccm.2009.08.014_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/JCM.42.1.212-219.2004","article-title":"IS6110 mediates increased transcription of the phoP virulence gene in a multidrug-resistant clinical isolate responsible for tuberculosis outbreaks","volume":"42","author":"Soto","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"17","key":"10.1016\/j.ccm.2009.08.014_bib35","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"issue":"34","key":"10.1016\/j.ccm.2009.08.014_bib36","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2009.05.050","article-title":"Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates","volume":"27","author":"Larsen","year":"2009","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.ccm.2009.08.014_bib37","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1016\/j.vaccine.2007.08.029","article-title":"Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin","volume":"25","author":"Waters","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ccm.2009.08.014_bib38","doi-asserted-by":"crossref","first-page":"e5264","DOI":"10.1371\/journal.pone.0005264","article-title":"MVA85A boosting of BCG and an attenuated, phoP deficient M tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques","volume":"4","author":"Verreck","year":"2009","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.ccm.2009.08.014_bib39","doi-asserted-by":"crossref","first-page":"19845","DOI":"10.1074\/jbc.M100662200","article-title":"Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier","volume":"276","author":"Camacho","year":"2001","journal-title":"J Biol Chem"},{"issue":"37\u201339","key":"10.1016\/j.ccm.2009.08.014_bib40","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","article-title":"Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis","volume":"24","author":"Sambandamurthy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2009.08.014_bib41","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6","volume":"69","author":"Weinrich Olsen","year":"2001","journal-title":"Infect Immun"},{"issue":"5\u20136","key":"10.1016\/j.ccm.2009.08.014_bib42","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.micinf.2005.03.011","article-title":"Tuberculosis vaccine development; from mouse to man","volume":"7","author":"Reed","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ccm.2009.08.014_bib43","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","article-title":"Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"23","author":"Langermans","year":"2005","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.ccm.2009.08.014_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.ccm.2009.08.014_bib45","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/14760584.6.5.741","article-title":"IC31 and IC30, novel types of vaccine adjuvant, based on peptide delivery systems","volume":"6","author":"Lingnau","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.ccm.2009.08.014_bib46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/icb.2009.14","article-title":"TB vaccines: current status and future perspectives","volume":"87","author":"Aagaard","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.ccm.2009.08.014_bib47","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1128\/IAI.67.8.3998-4007.1999","article-title":"Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis","volume":"67","author":"Skeiky","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.ccm.2009.08.014_bib48","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.ccm.2009.08.014_bib49","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1073\/pnas.0712077106","article-title":"Defined tuberculosis vaccine, Mtb72F\/AS02A, evidence of protection in cynomolgus monkeys","volume":"106","author":"Reed","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ccm.2009.08.014_bib50","first-page":"7","volume":"5","author":"Von Eschen","year":"2009","journal-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: Tolerability and immunogenicity in humans. Hum Vaccin"},{"key":"10.1016\/j.ccm.2009.08.014_bib51","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.ccm.2009.08.014_bib52","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1164\/rccm.200809-1486OC","article-title":"Safety and immunogenicity of a new TB vaccine, MVA85A, in M tuberculosis infected individuals","volume":"179","author":"Sander","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2009.08.014_bib53","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/jvi.62.5.1530-1534.1988","article-title":"Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination","volume":"62","author":"Rooney","year":"1988","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ccm.2009.08.014_bib54","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.00004-07","article-title":"Protective immune responses to an rAd35 TB vaccine in two mouse strains (H-2d vs H-2b): CD4 and CD8 T-cell epitope mapping and role of IFN\u03b3","volume":"75","author":"Radosevic","year":"2007","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.ccm.2009.08.014_bib55","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1099\/vir.0.81956-0","article-title":"Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells","volume":"87","author":"Havenga","year":"2006","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.ccm.2009.08.014_bib56","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2005.08.101","article-title":"Development of nonhuman adenoviruses as vaccine vectors","volume":"24","author":"Bangari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ccm.2009.08.014_bib57","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.184.3.993","article-title":"Identification of a heparin-binding hemagglutinin present in mycobacteria","volume":"184","author":"Menozzi","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.ccm.2009.08.014_bib58","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/35084083","article-title":"The heparin-binding haemagglutinin of M tuberculosis is required for extrapulmonary dissemination","volume":"412","author":"Pethe","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ccm.2009.08.014_bib59","first-page":"239","article-title":"The Koch phenomenon and the immunopathology of tuberculosis","volume":"215","author":"Rook","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2009.08.014_bib60","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.rmed.2005.09.026","article-title":"Immunological consequences of three doses of heat-killed M vaccae in the immunotherapy of tuberculosis","volume":"100","author":"Dlugovitzky","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2009.08.014_bib61","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2741\/1292","article-title":"Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis","volume":"9","author":"Stanford","year":"2004","journal-title":"Front Biosci"},{"key":"10.1016\/j.ccm.2009.08.014_bib62","unstructured":"Von Reyn CF, et\u00a0al. The DarDar prime-boost TB vaccine trial in HIV infection: final results [abstract PS-81689-20] in conference abstract book: 39th World Conference on Lung Health of the International Union against Tuberculosis and Lung Disease, Paris. Int J Tuberc Lung Dis 2008;12(11 S 2):S318."},{"issue":"3\u20134","key":"10.1016\/j.ccm.2009.08.014_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: a new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"author":"Tiernan","key":"10.1016\/j.ccm.2009.08.014_bib64"},{"author":"US Food and Drug Administration","key":"10.1016\/j.ccm.2009.08.014_bib65"},{"key":"10.1016\/j.ccm.2009.08.014_bib66","unstructured":"Centers for Disease Control and Prevention. History of vaccine safety. 28 Feb 2008. Available at: http:\/\/www.cdc.gov\/vaccinesafety\/basic\/history.htm%237. Accessed May 24, 2009."},{"author":"US Food and Drug Administration","key":"10.1016\/j.ccm.2009.08.014_bib67"},{"key":"10.1016\/j.ccm.2009.08.014_bib68","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2008.10.037","article-title":"The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases","volume":"122","author":"Al-Muhsen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"10.1016\/j.ccm.2009.08.014_bib69","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2009.08.014_bib70","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ccm.2009.08.014_bib71","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.180.3.1962","article-title":"Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response","volume":"180","author":"Scriba","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ccm.2009.08.014_bib72","doi-asserted-by":"crossref","first-page":"e1000392","DOI":"10.1371\/journal.ppat.1000392","article-title":"A critical role for CD8 T cells in a nonhuman primate model of tuberculosis","volume":"5","author":"Chen","year":"2009","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.ccm.2009.08.014_bib73","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1371\/journal.pmed.0050145","article-title":"Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations","volume":"5","author":"Hanekom","year":"2008","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.ccm.2009.08.014_bib74","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ccm.2009.08.014_bib75","series-title":"Handbook of tuberculosis: immunology and cell biology","first-page":"279","article-title":"Maintenance of latent infection, with correlates of protective immunity","author":"Hanekom","year":"2008"},{"key":"10.1016\/j.ccm.2009.08.014_bib76","doi-asserted-by":"crossref","unstructured":"Bennekov T, Dietrich J, Rosenkrands I, et\u00a0al. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Eur J Immunol 2006;36(12):3346\u201355.","DOI":"10.1002\/eji.200636128"},{"key":"10.1016\/j.ccm.2009.08.014_bib77","doi-asserted-by":"crossref","unstructured":"Forbes EK, Sander C, Ronan EO, et\u00a0al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol 2008;181(7):4955\u201364.","DOI":"10.4049\/jimmunol.181.7.4955"},{"key":"10.1016\/j.ccm.2009.08.014_bib78","doi-asserted-by":"crossref","unstructured":"Mittrucker HW, Steinhoff U, Kohler A, et\u00a0al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci U S A 2007;104(30):12434\u20139.","DOI":"10.1073\/pnas.0703510104"},{"key":"10.1016\/j.ccm.2009.08.014_bib79","unstructured":"US Food and Drug Administration. Center for Biologics Evaluation and Research: Guidance for industry: providing clinical evidence of effectiveness for human drugs and biological products. May 1998. Available at: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/Vaccines\/ucm074762.htm."},{"issue":"9","key":"10.1016\/j.ccm.2009.08.014_bib80","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1517\/14712598.4.9.1493","article-title":"Tuberculosis vaccine development: research, regulatory and clinical strategies","volume":"4","author":"Brennan","year":"2004","journal-title":"Expert Opin Biol Ther"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523109000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523109000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:45:03Z","timestamp":1759452303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523109000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0272523109000902"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2009.08.014","relation":{},"ISSN":["0272-5231"],"issn-type":[{"type":"print","value":"0272-5231"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Vaccines Against Tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2009.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}